Purchase Order 36C24622P0073

Award Date 10/1/21
Potential Completion Date 2/10/24
Potential Value $711K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Dublin, OH 43017, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Department of Veterans Affairs (VA) Veterans Health Administration to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The $150,662.24 firm fixed price purchase order is for the delivery of radiopharmaceuticals and related nuclear medicine products and services to support patient care programs at VA facilities. Cardinal Health 414 holds several indefinite delivery contracts with the VA to provide radiopharmaceuticals and specialty...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a firm fixed price delivery order contract to Cardinal Health 414, LLC for the provision of radiopharmaceuticals. The $339,148.52 contract, which does not have a set-aside designation, was awarded on October 1, 2017, with a completion date of November 6, 2018. Cardinal Health 414, a subsidiary of the global healthcare services company Cardinal Health, Inc., has provided a range of pharmaceutical products and...
This firm fixed-price purchase order was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract, which has no set-aside designation, is for the delivery of radiopharmaceuticals and nuclear medicine supplies to support VA healthcare facilities. The potential value of the contract is $192,841.66, with a completion date of September 30, 2018. Cardinal Health 414 holds several indefinite...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cardinal Health 414, LLC, a subsidiary of the global healthcare company Cardinal Health, Inc. The contract, valued at $57,000.00, is for the delivery of radiopharmaceuticals, radioactive isotopes, and other specialty pharmaceutical products to support nuclear medicine, oncology, and patient care programs at VA facilities. Cardinal Health 414 has extensive experience...
This $161,525.58 firm-fixed-price purchase order was awarded to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., by the Department of Veterans Affairs (VA) for the supply of radiopharmaceuticals. The contract has no set-aside designation and an ultimate completion date of September 30, 2025. Cardinal Health 414 is a major supplier of nuclear medicine products and services to federal healthcare agencies, including the VA, Department of Defense, and National Institutes of Health....
This is a firm fixed price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., for radiopharmaceuticals. The $387,031.15 order is part of a larger VA Veterans Integrated Service Network 8 contract to provide radiopharmaceuticals and related nuclear medicine supplies and services to VA facilities in Miami, Florida. Cardinal Health 414 has held several indefinite delivery contracts with...
The U.S. Department of Veterans Affairs (VA) awarded a delivery order contract with a ceiling value of $856,500.00 to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the multi-station purchase of radiopharmaceuticals to support nuclear medicine, oncology, and diagnostic imaging services at various VA medical facilities. The contract is a firm fixed-price delivery order without a set-aside designation, reflecting the specialized nature of the...
This is a delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cardinal Health 414, LLC, a subsidiary of the global healthcare firm Cardinal Health, Inc. The $431,030.86 firm fixed price contract is for the delivery of radiopharmaceuticals to support nuclear medicine, oncology, and other patient care programs at VA facilities. Cardinal Health 414 holds several indefinite delivery vehicle (IDV) contracts with the VA to provide radiopharmaceuticals...
This is a federal contract award by the Department of Veterans Affairs (VA) Veterans Health Administration to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of radiopharmaceuticals to the VA's Veterans Integrated Service Network 8, which covers facilities in Florida and the Caribbean. The contract has a potential value of $254,772.81 and is a firm fixed price delivery order with no set-aside designation. Cardinal Health 414 has provided a range...
This is a $726,265.90 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., for the supply of radiopharmaceuticals. The contract, which has no set-aside designation, is for the delivery of critical medical isotopes and radiopharmaceutical products used in nuclear medicine, oncology, and diagnostic imaging services to support the VA healthcare system. Cardinal Health 414 is an...

Cardinal Health 414, LLC was awarded a firm fixed price purchase order totaling $710,585.29 to provide radiopharmaceuticals under an indefinite delivery contract vehicle. The award originated from a Request for Quote issued by the Department of Veterans Affairs seeking various technetium, gallium, indium, cobalt and fluorodeoxyglucose radiopharmaceuticals, as well as calibration sources, for nuclear medicine imaging procedures at three VA medical centers. Delivery within 120 minutes is required for some short-lived isotopes. Cardinal Health 414 will supply the radiopharmaceuticals through its existing IDV with the VA worth up to $39.8 million to multiple Florida and Caribbean medical centers through September 2027. This purchase order has no set-aside designation and supports the VA's nuclear medicine and oncology programs.

Generated 3/12/24, 9:43 PM